SOURCE: Cypress Bioscience, Inc.

September 25, 2006 06:30 ET

Cypress Bioscience, Inc. to Present at UBS Global Life Sciences Conference

SAN DIEGO, CA -- (MARKET WIRE) -- September 25, 2006 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Business Officer and Chief Financial Officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 27, 2006.

The UBS Global Life Sciences conference is being held at the Grand Hyatt Hotel, New York, NY. Ms. Johnson is scheduled to present on Wednesday, September 27th at 8:00 a.m. Eastern Time.

Investors, analysts and the general public are invited to listen to a live audio broadcast of this presentation over the Internet. The broadcast can be accessed at (find the Conferences link in the middle right side of the page, click on the graphic link, follow link for Webcast next to the 2006 Global Life Science Conference).

A replay of the presentation will be available at the same web address as well as on Cypress' website,

About Cypress Bioscience, Inc.

Cypress is committed to being the innovator and leader in providing products that improve the treatment of Functional Somatic Syndromes and other central nervous system conditions. Cypress' strategy involves acquiring/in-licensing undervalued central nervous system active compounds and developing them for new indications.

For more information about Cypress, please visit the Company's web site at

Contact Information

  • For additional information please contact

    For Cypress Bioscience:
    Sabrina Martucci Johnson
    Executive VP, Chief Business Officer and Chief Financial Officer

    Investor Relations
    (858) 452-2323